That is essential, due to the fact that the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. In other words, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (tech predictions). Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're created to do. This was a breakthrough nearly nobody saw. However it's going to have profound implications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment opportunities in this area, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (last week). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps significantly prior to going higher - brownstone research stock. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily educating readers. But that's not the big question any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. genetic sequencing companies jeff brown. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are many fantastic private companies on the edge of hitting the public markets And I have actually been dealing with a brand-new method for you to invest even prior to these companies go public.
This opportunity has actually been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your area totally free.
Emma Walsh here, managing editor of the Diary. Routine Diary readers know that tech isn't our usual beat (jeff brown investment prediction). And when it comes to tech investing, we leave it to the experts. Luckily, we have several such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we know (what is the legacy report predicting). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big image and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These trends are experiencing exponential growth and developing unbelievable chances for investors. I want to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown 2020 predictions. But in spite of what numerous readers might believe, this is a pattern that's just beginning. Although the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown investment prediction). Losing 2 months of manufacturing and sales actually affects the number of 5G gadgets are offered in the fiscal year. When you consider all of that, selling 250 million systems is exceptional. More significantly, the hold-ups caused by the pandemic developed a lots of suppressed demand. And that demand is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G devices will be delivered in 2021 - jeff brown tech stock 2021. Which's not my only 5G forecast When I've talked about 5G in the past, I've explained its three different phases.
In Stage Two, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Stage 3, 5G services start to be provided (white house). That's when we start to see applications working on 5G networks. Consider things like massive multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage Three by this summer. This begins something of a virtuous cycle: Most people do not truly care about the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open up a suite of incredible applications: self-driving cars, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next important technology I anticipate in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software application.
The program can crash or not function properly. CRISPR utilizes a comparable concept but with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For many years, CRISPR was primarily a niche technology that wasn't well comprehended. And during that time, there were truly just 3 companies running in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating diseases and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This whole industry is effectively a greenfield opportunity.
There's room for numerous companies to exist in this space. jeff brown biotech genome sequencing. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things happening at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software can precisely forecast the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That is essential since the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental process. Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're developed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however several drug treatments produced using this technology. This was among those advancements that practically no one saw. But it's going to have profound implications for treating illness. And, of course, there will be a lot of financial investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it pulled back perhaps significantly before going greater. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin - toxic tech 5 tech darlings. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. But at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. democratic republic. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the information depends on date as of February 2021, however we might not separately verify this claim. Provided Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this moment. Brown is best known for his sage-like ability to pick winning technology stocks. He spent more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an outstanding point of view on the marketplace. He's always on the hunt for brand-new chances, and he shares a lot of his finest choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he successfully predicted a few of the greatest economic occasions of the previous twenty years. Although he doesn't appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it right every time, but Jeff Brown's accurate forecasts have earned him legions of devoted followers. That states a lot about his capability. The Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research study offers a number of research study services with a variety of expertises - black sea.
The business is also connected with Bonner & Partners, another well-respected research publisher - last year. On its site, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the very best investment research study has actually not been offered to specific financiers. It has actually been normally booked for financial investment banks, hedge funds, personal equity, and high-net-worth customers. toxic tech 5 tech darlings. The objective of Brownstone Research study is to make that type of proprietary research study offered to any financiers looking to acquire an edge in the markets. The goal is simple to deliver special and successful investment research study discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research, and he also serves as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After decades of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout many of America. If you understand even a little bit about the market, you understand that he has a credibility as a King Midas of sorts. jeff bezos. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown thinks S.A.V. jeff brown biotech stock pick for 2020. might be "the greatest pattern of the 2020s, and he's not alone. Check out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge innovations: expert system and electric cars. Musk hopes the combination will assist him develop the first fully-autonomous, self-driving cars ever. It's nothing except the vehicle industry's Holy Grail. As you know, electrical automobiles and self-driving vehicle stocks have been big this year, but the Wall Street device has approved buzz without much tangible result. In spite of an extreme increase in competition over the past couple of years, Brown still believes Musk has the best chance of putting everything together.
tech could be the magic string that ties everything together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transport. Generally, this innovation would allow you to lease out your car as an autonomous, self-driving taxi when you're not utilizing it. You simply leave the cars and truck and press a button on an app that informs the car to "join the fleet." Next thing you understand, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a substantial piece of the earnings. It sounds insane, however it might be closed than you think.